Evaluating Pioglitazone for Managing Type 2 Diabetes Mellitus in Patients with Nonalcoholic Fatty Liver Disease
In T2DM patients with NAFLD, pioglitazone improves glycemic control and reduces both fatty liver grades and fibrosis stages.
Authors
- Aditi Mahajan (ORCID: https://orcid.org/0000-0001-5318-5625)
- Vijay Panikar
- Divya Lalwani
- Ishita Sachdev
- Krish Panikar
- Nikhil Nasikkar
- Harshpreet Tuteja
- Narayan Deogaonkar
- Jimit Vadgama
- Apoorva Gupta (ORCID: https://orcid.org/0000-0001-6534-2835)
- Samiksha Singh
- Parveen Kader
- Sanhita Walwalkar
- Shashank Joshi
- Mangesh Tiwaskar
Institutions
- Amrita Institute of Medical Sciences and Research Centre (IN)
- Lilavati Hospital & Research Centre (IN)
- Sarguja University (IN)
- Swami Ramanand Teerth Rural Medical College (IN)
- Diabetes Care and Research Foundation (IN)
- Diabetes Care & Hormone Clinic (IN)
- ORCID (US)
- Indian Numismatic, Historical and Cultural Research Foundation (IN)
- Dr. Kovil's Diabetes Care Centre (IN)
Publication Details
- Journal
- Journal of the Association of Physicians of India
- Published
- 2025-11-10
- DOI
- https://doi.org/10.59556/japi.73.1250
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00